One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Flashback Foreword: Concurrent Chemotherapy/Radiotherapy for Cervical Cancer.
Fleming, Gini F. MD 1,2,,
doi : 10.1200/JCO.23.00092
Volume 41(29) pgs. 4603-4709 October 10, 2023
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix.
Peters, William A. III; Liu, P.Y.; Barrett, Rolland J. II; Stock, Richard J.; Monk, Bradley J.; Berek, Jonathan S.; Souhami, Luis; Grigsby, Perry; Gordon, William Jr; Alberts, David S.
doi : 10.1200/JCO.22.02769
To Inhibit or Not to Inhibit MEK With BRAF Inhibitors: Is That the Question?.
Sullivan, Ryan J. MD 1,,
doi : 10.1200/JCO.23.01380
Timing and Reporting of Secondary Overall Survival End Points for Phase III Trials in Advanced/Metastatic Disease.
Freidlin, Boris PhD 1,,; Korde, Larissa A. MD 2; Korn, Edward L. PhD 1
doi : 10.1200/JCO.23.00413
Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial.
Ascierto, Paolo A. MD 1,,; Dummer, Reinhard MD, PhD 2,; Gogas, Helen J. MD, PhD 3,; Arance, Ana MD, PhD 4,; Mandala, Mario MD 5,; Liszkay, Gabriella MD, PhD 6,; Garbe, Claus MD, PhD 7,; Schadendorf, Dirk MD, PhD 8,9,; Krajsova, Ivana MD 10; Gutzmer, Ralf MD 11,; Chiarion-Sileni, Vanna MD 12,; Dutriaux, Caroline MD, PhD 13,; de Groot, Jan Willem B. MD, PhD 14; Yamazaki, Naoya MD, PhD 15,; Loquai, Carmen MD 16; Robert, Caroline MD, PhD 17,; Flaherty, Keith T. MD 18,
doi : 10.1200/JCO.22.02322
Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial.
Ling, Yiwen MD, PhD 1,2,3; Xuan, Li MD, PhD 1,2; Xu, Na MD, PhD 1,2; Huang, Fen MD 1,2; Fan, Zhiping MD 1,2; Guo, Ziwen MD 4; Xu, Xiaojun MD, PhD 5; Liu, Hui MD, PhD 1,2; Lin, Ren MD, PhD 1,2; Yu, Sijian MD, PhD 1,2; Zhang, Haiyan MD, PhD 1,2; Jin, Hua MD, PhD 1,2; Wu, Meiqing MD, PhD 6; Liu, Can MD, PhD 7; Liang, Xinquan MD 8; Ou, Ruiming MD 9; Zhang, Yuping MD 10; Liu, Xiaodan MD, PhD 11; Qu, Hong MD, PhD 12; Zhai, Xiao MD 13; Sun, Jing MD 1,2; Zhao, Ying MD 3; Liu, Qifa MD 1,2,
doi : 10.1200/JCO.23.00101
Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma.
Hall, William A. MD 1,,; Li, Jiahe MS 2; You, Y. Nancy MD 3; Gollub, Marc J. MD 4,; Grajo, Joseph R. MD 5,6; Rosen, Mark MD 7; dePrisco, Greg MD 8; Yothers, Greg PhD 2,; Dorth, Jennifer A. MD 9,; Rahma, Osama E. MD 10,; Russell, Marcia M. MD 11,; Gross, Howard M. MD 12; Jacobs, Samuel A. MD 13,; Faller, Bryan A. MD 14,; George, Sagila MD 15,; Al baghdadi, Tareq MD 16,; Haddock, Michael G. MD 17; Valicenti, Richard 18; Hong, Theodore S. MD 19,; George, Thomas J. MD 5,6,
doi : 10.1200/JCO.22.02525
Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39).
Blinder, Victoria S. MD, MSc 1,; Deal, Allison M. MS 2; Ginos, Brenda MS 3; Jansen, Jennifer MPH 2; Dueck, Amylou C. PhD 3; Mazza, Gina L. PhD 3; Henson, Sydney BS 2; Carr, Philip MPH 2; Rogak, Lauren J. MA 1; Weiss, Anna MD 4,; Rapperport, Anna BA 5,; Jonsson, Mattias BA 2,; Spears, Patricia A. BS 2,; Cella, David PhD 6,; Gany, Francesca MD, MSc 1,; Schrag, Deborah MD, MPH 1,; Basch, Ethan MD, MSc 2,
doi : 10.1200/JCO.22.02834
Projected Savings for Generic Oncology Drugs Purchased via Mark Cuban Cost Plus Drug Company Versus in Medicare.
Cortese, Brian D. BS 1,2; Dusetzina, Stacie B. PhD 3,4; Luckenbaugh, Amy N. MD 5; Al Hussein Al Awamlh, Bashir MD 5; Stimson, C.J. MD, JD 5; Barocas, Daniel A. MD, MPH 5; Penson, David F. MD, MPH 5; Chang, Sam S. MD, MBA 4,5; Talwar, Ruchika MD 5,
doi : 10.1200/JCO.23.00079
Impact of Breast Cancer Screening on 10-Year Net Survival in Canadian Women Age 40-49 Years.
Wilkinson, Anna N. MD, MSc, CCFP 1,,; Ellison, Larry F. MSc 2; Billette, Jean-Michel PhD 2; Seely, Jean M. MD, FRCPC 3
doi : 10.1200/JCO.23.00348
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01.
Shimizu, Toshio MD, PhD 1,2,,; Sands, Jacob MD 3,; Yoh, Kiyotaka MD 4,; Spira, Alexander MD 5,; Garon, Edward B. MD, MS 6,; Kitazono, Satoru MD 7,; Johnson, Melissa L. MD 8,; Meric-Bernstam, Funda MD 9,; Tolcher, Anthony W. MD 10,; Yamamoto, Noboru MD, PhD 1,; Greenberg, Jon BA, MA, MD 11,; Kawasaki, Yui PhD 12,; Zebger-Gong, Hong MD, PhD 11,; Kobayashi, Fumiaki PhD, MS 13,; Phillips, Penny PhD 12,; Lisberg, Aaron E. MD 6,; Heist, Rebecca S. MD, MPH 14,
doi : 10.1200/JCO.23.00059
Targeting Trop-2 as a Cancer Driver.
Guerra, Emanuela PhD 1,2,; Trerotola, Marco PhD 1,2; Alberti, Saverio MD, PhD 3,,
doi : 10.1200/JCO.23.01207
What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission?.
DeWolf, Susan MD 1,,; Tallman, Martin S. MD 2,; Rowe, Jacob M. MD 3,4,; Salman, Meira Yisraeli MD 4
doi : 10.1200/JCO.22.02868
Evaluating the Duration of Response With Mirvetuximab Soravtansine for Treating Platinum-Resistant Ovarian Cancer.
McCaw, Zachary R. PhD; Tian, Lu ScD; Wei, Lee-Jen PhD
doi : 10.1200/JCO.23.00288
Reply to Z.R. McCaw et al.
Matulonis, Ursula A. MD; Lorusso, Domenica MD; Oaknin, Ana MD, PhD; Pignata, Sandro MD; Dean, Andrew MD; Denys, Hannelore MD, PhD; Colombo, Nicoletta MD; Van Gorp, Toon MD; Konner, Jason A. MD; Marin, Margarita Romeo MD; Harter, Philipp MD; Murphy, Conleth G. MD; Wang, Jiuzhou PhD; Noble, Elizabeth BS; Esteves, Brooke BS; Method, Michael MD; Coleman, Robert L. MD
doi : 10.1200/JCO.23.00752
Inconsistent Data Between Distant Relapse Events and Breast Cancer-Specific Death Events in India Lidocaine Trial.
Yu, Ke-Da MD, PhD
doi : 10.1200/JCO.23.00976
Painfully Absent.
Broens, Suzanne MD, PhD; van Duijnhoven, Frederique H. MD, PhD; Hollmann, Markus W. MD, PhD; Hemmes, Sabrine N.T. MD, PhD
doi : 10.1200/JCO.23.01063
Reply to S. Broens et al and K.-D. Yu.
Badwe, Rajendra Achyut MS; Joshi, Shalaka MS, MCh, MRes; Hawaldar, Rohini BSc, DCM; Gupta, Sudeep MBBS, MD, DM (Medical Oncology)
doi : 10.1200/JCO.23.01209
